News OECD calls for 'rebalancing of power' in drug price negotiat... Health systems should fund more treatments for chronic diseases, says EFPIA
Articles EFPIA’s director general, Richard Bergström, on market acces... He says the industry will partner with payers to deliver outcomes-driven, sustainable healthcare, in pharmaphorum's magazine Deep Dive: Market Access.
News Brexit: could European Medicines Agency stay in London? Pharma wants single regulatory system to remain.
News Countdown to European pharma transparency begins EFPIA's Disclosure Code will come into force on June 30.
Articles Countdown to pharma disclosure in Europe – but cultural divi... Pharma is getting ready to disclose full data on payments to doctors across Europe for the first time – but big cultural differences across the continent will complicate matters.
Oncology LSX2026: Addressing adult eye cancer, with Roi Raz Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
